Self-contained training for stroke patients during inpatient rehabilitation

ISRCTN ISRCTN42633681
DOI https://doi.org/10.1186/ISRCTN42633681
Secondary identifying numbers 1-2016
Submission date
23/07/2017
Registration date
02/08/2017
Last edited
25/11/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
A stroke occurs when the blood supply is cut off to the brain. A majority of stroke patients are affected by an impaired function of the upper extremity (upper body and arms). Numerous studies have indicated that there is a relationship between intensity and amount of training on the one hand and improvement of functions on the other hand. Usually, patients with a severe paresis (muscle weakness) of the upper extremity are treated with the ArmeoSpring exoskeleton during their inpatient rehabilitation. An exoskeleton is a frame that is put on the arm to help support the arm weight and help improve function. The aim of this study is to examine what happens when treatment time with this device is increased without investing additional personnel.

Who can participate?
Stroke patients aged 18 to 85

What does the study involve?
Participants receive 24 training sessions with the exoskeleton over four weeks. This is connected to a computer that offers virtual reality. The degree in which they can move their arm while in the exoskeleton is recorded.

What are the possible benefits and risks of participating?
Participants may benefit from improvements in motor function. The device is safe and has a certificate allowing to use it for patient treatment. There are no known risks.

Where is the study run from?
Kliniken Schmieder (Germany)

When is the study starting and how long is it expected to run for?
February 2016 to February 2017

Who is funding the study?
Kliniken Schmieder (Germany)

Who is the main contact?
Prof. Dr. Joachim Liepert
j.liepert@kliniken-schmieder.de

Contact information

Prof Joachim Liepert
Public

Kliniken Schmieder
Zum Tafelholz 8
Allensbach
78476
Germany

Phone +49 7533 808 1236
Email j.liepert@kliniken-schmieder.de

Study information

Study designAn interventional study with the ArmeoSpring exoskeleton used as a device for additional self-contained training in evenings and on weekends. The study explores feasibility and acceptance. It is single-centre because it is a pilot study
Primary study designInterventional
Secondary study designNon randomised study
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet. Contact: j.liepert@kliniken-schmieder.de
Scientific titleUsing an upper extremity exoskeleton for semi-autonomous exercise during inpatient neurological rehabilitation- a pilot study
Study objectivesA self-contained robot-assisted training in addition to conventional inpatient rehabilitation is feasible.
Ethics approval(s)University of Constance, 21/04/2016
Health condition(s) or problem(s) studiedStroke patients
InterventionParticipants receive self-contained training with the Armeo Spring exoskeleton over a period of four weeks with up to 24 treatment sessions.

The exoskeleton is connected to a computer that offers a variety of games in a virtual reality environment. For example, patients can paint a room, can grasp objects in a supermarket, can catch balls and so on. The degree to which the patients can move the arm while it is positioned in the exoskeleton is determined. Movements visible on the screen are adjusted to this individual level of performance.

There is no follow up.
Intervention typeDevice
Pharmaceutical study type(s)
Phase
Drug / device / biological / vaccine name(s)
Primary outcome measureFeasibility (recording of side effects or adverse events) is measured using a structured interview once a week during the 4 weeks. Patients and supervisors are interviewed after the first, second, third and fourth week.
Secondary outcome measuresAcceptance is measured using the visual analogue scale at the end of the treatment period (after 4 weeks)
Motor function is measured using Wolf Motor Function Test at baseline and after 4 weeks of additional therapy.
Overall study start date02/02/2016
Completion date08/02/2017

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit85 Years
SexBoth
Target number of participants10
Total final enrolment10
Key inclusion criteria1. Treatment in a neurological rehabilitation hospital for > 4 weeks
2. Stroke patients
3. Severe upper limb paresis
4. Ability to understand instructions and make own decisions
5. Aged 18-85 years old
Key exclusion criteria1. Unwillingness to participate
2. Inability to understand the instructions
Date of first enrolment02/05/2016
Date of final enrolment06/01/2017

Locations

Countries of recruitment

  • Germany

Study participating centre

Kliniken Schmieder
Zum Tafelholz 8
Allensbach
78476
Germany

Sponsor information

Kliniken Schmieder
Hospital/treatment centre

Zum Tafelholz 8
Allensbach
78476
Germany

ROR logo "ROR" https://ror.org/04bkje958

Funders

Funder type

Hospital/treatment centre

Kliniken Schmieder

No information available

Results and Publications

Intention to publish date12/08/2017
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planWe plan to publish data on feasibility, acceptance and changes of motor functions.
IPD sharing planThe datasets generated during and/or analysed during the current study are/will be available upon request from Dr. Joachim Liepert; email: j.liepert@kliniken-schmieder.de

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 02/08/2018 25/11/2020 Yes No

Editorial Notes

25/11/2020: Publication reference and total final enrolment number added.